Overview

Safety and Efficacy Study of Adjunctive Antiplatelet Therapy Prior to Primary PCI in Patients With STEMI

Status:
Terminated
Trial end date:
2008-07-01
Target enrollment:
Participant gender:
Summary
Safety and efficacy of adjunctive antiplatelet therapy prior to primary percutaneous intervention (PCI) in patients with ST-Elevation Myocardial Infarction (STEMI)
Phase:
Phase 2
Details
Lead Sponsor:
Portola Pharmaceuticals